BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Medicine by Design - ECPv6.15.18//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Medicine by Design
X-ORIGINAL-URL:https://mbd.ccrm.ca
X-WR-CALDESC:Events for Medicine by Design
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/Toronto
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20210314T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20211107T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20220313T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20221106T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20230312T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20231105T060000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=America/Toronto:20221110T120000
DTEND;TZID=America/Toronto:20221110T130000
DTSTAMP:20260403T142647
CREATED:20220627T132515Z
LAST-MODIFIED:20221026T204249Z
UID:17497-1668081600-1668085200@mbd.ccrm.ca
SUMMARY:Global Speaker Series: Martin Fussenegger\, PhD – ETH Zurich
DESCRIPTION:The Medicine by Design Global Speaker Series invites established and emerging international leaders in regenerative medicine to engage with our extraordinary community of researchers and clinicians. Medicine by Design\, in partnership with the McEwen Stem Cell Institute\, is pleased to welcome Martin Fussenegger\, PhD\, Professor\, Department of Biosystems Science and Engineering\, ETH Zurich. The title of this talk will be\, “Toward A World of ElectroGenetics” \nIn Person – Register Here\nVirtual – Register Here\nHybrid event\, with in-person and virtual options\n\nIn-person will be held at the Terrence Donnelly Centre for Cellular & Biomolecular Research\, Red Room.\nVirtual event links will be sent after registration.\n\nMORE ABOUT MARTIN FUSSENEGGER: \n \nMartin Fussenegger is Professor of Biotechnology and Bioengineering at the Department of Biosystems Science and Engineering (D-BSSE) of the ETH Zurich in Basel as well as at the University of Basel.His research focuses on mammalian cell engineering\, in particular on the assembly of synthetic gene circuits that process complex control and closed-loop expression logic as well as on the production of theranostic designer cell implants that interface with host metabolism to correct prominent metabolic disorders. \nMartin Fussenegger graduated with Werner Arber at the Biocenter of the University of Basel (1992)\, obtained his Ph.D. in Medical Microbiology (1994) at the Max Planck Institute of Biology (Tübingen\, Germany) and continued his postdoctoral studies on host-pathogen interactions at the Max Planck Institute of Infection Biology (Berlin\, 1995). He then joined the ETH Institute of Biotechnology (1996)\, where he received his habilitation in 2000\, and became Swiss National Science Foundation Professor of Molecular Biotechnology in 2002\, prior to being awarded a Chair in Biotechnology and Bioengineering at the ETH Institute for Chemical and Bioengineering in 2004. \nMartin Fussenegger received the Gaden Award\, the Merck Cell Culture Engineering Award\, the Medal of the European Society for Animal Cell Technology (ESACT)\, the Gutenberg Chair Excellence Award\, the James E. Bailey Award and two consecutive Advanced Grant Awards of the European Research Council. \n Learn more about Martin Fussenegger
URL:https://mbd.ccrm.ca/event/global-speaker-series-martin-fussenegger-phd-eth-zurich-2/
LOCATION:Donnelly Centre for Cellular and Biomolecular Research\, Red Room\, 160 College Street\, Toronto\, Ontario\, M5S 3E1\, Canada
CATEGORIES:Global Speaker Series
ORGANIZER;CN="Medicine by Design":MAILTO:info.mbd@utoronto.ca
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Toronto:20221110T113000
DTEND;TZID=America/Toronto:20221110T123000
DTSTAMP:20260403T142647
CREATED:20220330T210935Z
LAST-MODIFIED:20220330T210935Z
UID:16873-1668079800-1668083400@mbd.ccrm.ca
SUMMARY:Modelling Cell Development & Regeneration Discussion Group
DESCRIPTION:Please visit the discussion groups page for more information.
URL:https://mbd.ccrm.ca/event/modelling-cell-development-regeneration-discussion-group-17/
LOCATION:Online
CATEGORIES:Discussion Groups
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Toronto:20221103T150000
DTEND;TZID=America/Toronto:20221103T163000
DTSTAMP:20260403T142647
CREATED:20221019T190417Z
LAST-MODIFIED:20221027T150643Z
UID:18682-1667487600-1667493000@mbd.ccrm.ca
SUMMARY:Program Information Session: Building a Biotech Venture 2023
DESCRIPTION:Join us on November 3 for an information session to learn about the Building a Biotech Venture Program.\nRegister for the info session\nTake your first steps toward entrepreneurship with the Building a Biotech Venture program\, a program for trainees who are doing regenerative medicine- or precision medicine-related research in labs at the University of Toronto or its affiliated hospitals. \nMedicine by Design is offering this program in partnership with Precision Medicine Initiative (PRiME) as well as our foundational partners the Health Innovation Hub (H2i)\, a campus-linked accelerator at the Temerty Faculty of Medicine; and Talk Boutique. \nThrough a series of workshops over winter/spring 2023\, teams will\n-Learn how to think about their research in terms of a product or business;\n-Build a business canvas and develop their product or venture concept;\n-Receive guidance from industry experts on intellectual property\, clinical translation\, and early-stage stage investment.\n-Create a pitch deck and receive coaching on telling their venture story; and\n-Receive regular mentoring from entrepreneurs throughout the process. \nThe program will culminate in a pitch competition in April 2023\, where the first-place team will receive $25\,000 in research funding to advance their product concept.\n \nProgram Information Session and Networking\nNovember 3\, 3 p.m. to 4:30 p.m.\nThe information session will provide an overview of the program and an introduction to H2i’s 10-point plan\, which outlines 10 key elements of a business canvas. Completing a business canvas is a component of the program application. The session will be followed by networking where you can meet like-minded trainees to form your team. \n\nBuilding a Biotech Venture program breakdown:\n\nThe Building a Biotech Venture Program occurs in two phases: \nVenture Development (January-March 2022)– Ten teams will develop their ventures with guidance and training through mentorship and workshop programing. Workshops will be run by industry experts to help in scaling their ventures and prepare them for the pitch competition.\nWorkshop 1: Mentor introduction event (January)\nWorkshop 2: Intellectual property (January)\nWorkshop 3: Clinical translation and regulatory affairs (February)\nWorkshop 4: Early-stage investment (February)\nWorkshop 5: Pitching and presentation skills workshop (March) \nPitch Competition – Teams will receive pitch coaching\, and compete in a pitch competition to a panel of industry experts. Teams accepted into the Venture Development phase of the program are eligible to participate in the Pitch Development phase but will need to submit a separate application once it opens in late February. Select teams will pitch for a chance to receive $25\,000 in research funding.
URL:https://mbd.ccrm.ca/event/info-session-biotech-venture-2023/
LOCATION:ONRamp\, 100 College St\, Suite 150\, Toronto\, M5G 1L5\, Canada
CATEGORIES:Partner Events,Workshops
ORGANIZER;CN="Medicine by Design":MAILTO:info.mbd@utoronto.ca
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Toronto:20221031T140000
DTEND;TZID=America/Toronto:20221031T150000
DTSTAMP:20260403T142647
CREATED:20220322T171518Z
LAST-MODIFIED:20220322T171545Z
UID:16796-1667224800-1667228400@mbd.ccrm.ca
SUMMARY:Myogenesis Discussion Group
DESCRIPTION:Please visit the discussion groups page for more information.
URL:https://mbd.ccrm.ca/event/myogenesis-discussion-group-13/
LOCATION:Online
CATEGORIES:Discussion Groups
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Toronto:20221027T113000
DTEND;TZID=America/Toronto:20221027T123000
DTSTAMP:20260403T142647
CREATED:20220329T182751Z
LAST-MODIFIED:20220329T182751Z
UID:16862-1666870200-1666873800@mbd.ccrm.ca
SUMMARY:Modelling Cell Development & Regeneration Discussion Group
DESCRIPTION:Please visit the discussion groups page for more information.
URL:https://mbd.ccrm.ca/event/modelling-cell-development-regeneration-discussion-group-16/
LOCATION:Online
CATEGORIES:Discussion Groups
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Toronto:20221025T120000
DTEND;TZID=America/Toronto:20221025T130000
DTSTAMP:20260403T142647
CREATED:20220322T175316Z
LAST-MODIFIED:20220322T175316Z
UID:16815-1666699200-1666702800@mbd.ccrm.ca
SUMMARY:Adipose Biology Seminar Series
DESCRIPTION:Please visit the discussion groups page for more information.
URL:https://mbd.ccrm.ca/event/adipose-biology-seminar-series-16/
LOCATION:Online
CATEGORIES:Discussion Groups
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Toronto:20221018T120000
DTEND;TZID=America/Toronto:20221018T130000
DTSTAMP:20260403T142647
CREATED:20220627T132215Z
LAST-MODIFIED:20221011T130800Z
UID:17500-1666094400-1666098000@mbd.ccrm.ca
SUMMARY:Global Speaker Series: Jacob Hanna\, MD\, PhD -Weizmann Institute of Science
DESCRIPTION:The Medicine by Design Global Speaker Series invites established and emerging international leaders in regenerative medicine to engage with our extraordinary community of researchers and clinicians. Medicine by Design\, in partnership with the McEwen Stem Cell Institute\, is pleased to welcome Jacob Hanna\, MD\, PhD\, Senior Scientist and Professor\, Department of Molecular Genetics\, Weizmann Institute of Science. The title of this talk will be\, “Synthetic Ex Utero Embryogenesis: from Naive Pluripotent Stem Cells to Advanced Whole Embryos”. \nIn Person – Register Here \nVirtual – Register Here\nHybrid event\, with in-person and virtual options\n\nIn-person will be held at the Terrence Donnelly Centre for Cellular & Biomolecular Research\, Red Room.\nVirtual event links will be sent after registration.\n\nMORE ABOUT JACOB HANNA: \nBorn in Rama\, an Arab Palestinian village in the Galilee region of Israel\, Professor Jacob (Yaqub) Hanna earned his BSc in medical science\, PhD in immunology\, and MD in clinical medicine summa cum laude from the Hebrew University of Jerusalem. He conducted postdoctoral research at the Whitehead Institute for Biomedical Research at MIT. He joined the department of Molecular Genetics at the Weizmann Institute in 2011. \nProfessor Hanna is pioneering techniques in induced naïve pluripotency from adult cell and synthetic whole embryo models made solely from stem cells ex utero. Professor Hanna was the lead researcher in a study that showed how further-modified iPS cells could be used to treat sickle-cell anemia in mice\, the first proof of concept of the therapeutic application of iPS cells. \nDuring his postdoctoral work\, Professor Hanna received a prestigious Novartis Fellowship from the Helen Hay Whitney Foundation. In 2010\, he was awarded the Sir Charles Clore Prize for Outstanding Appointment in the Weizmann Institute. He received an EMBO Young Investigator Award (2012)\, a Rappaport Prize in biomedical research (2013)\, a Krill Prize by the Wolf Foundation (2013)\, and the Helen and Martin Kimmel Award for Innovative Investigation (2014). In 2014\, he was featured among “40 under 40” innovative scientists by the prestigious journal Cell and was elected as a member of EMBO in 2018. In 2021\, he ranked at the top of the list of 50 leading world thinkers by Prospect magazine. \n Learn more about Jacob (Yaqub) Hanna
URL:https://mbd.ccrm.ca/event/global-speaker-series-jacob-hanna-phd-weizmann-institute-of-science/
LOCATION:Donnelly Centre for Cellular and Biomolecular Research\, Red Room\, 160 College Street\, Toronto\, Ontario\, M5S 3E1\, Canada
CATEGORIES:Global Speaker Series
ORGANIZER;CN="Medicine by Design":MAILTO:info.mbd@utoronto.ca
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Toronto:20221013T120000
DTEND;TZID=America/Toronto:20221013T130000
DTSTAMP:20260403T142647
CREATED:20220714T163511Z
LAST-MODIFIED:20220816T213015Z
UID:17726-1665662400-1665666000@mbd.ccrm.ca
SUMMARY:Beyond Academia - Betty Zou\, PhD Research and Communications Specialist\, University of Toronto and Adriana Suarez-Gonzalez\, PhD Science and Technology Advisor\, 10X Genomics
DESCRIPTION:About the series \nTo what extent can we plan and design our careers? How much depends on our environment\, the choices we make\, the opportunities that present themselves\, the networks we build\, and the achievements and failures we experience along the way? Medicine by Design and Stem Cell Network have partnered to host Careers Beyond Academia\, a virtual career seminar series that will profile a wide variety of different careers available to trainees who hold a degree in the life sciences. The goal of the series is to help trainees understand the different careers available outside of academia\, the skills required for certain positions\, and some of the daily functions of those positions. \n Virtual Event – Register Here\nSpeakers:\n\nBetty Zou\, PhDResearch and Communications Specialist\, University of Toronto\nAdriana Suarez-Gonzalez\, PhDScience and Technology Advisor\, 10X Genomics\n\nEach session will feature two speaker presentations that will be recorded and available on both Medicine by Design and Stem Cell Network’s website and YouTube channel. Trainees will be able to participate in a joint Q&A and panel discussion during the session. \n 
URL:https://mbd.ccrm.ca/event/beyond-academia-speaker-tbc-2/
LOCATION:Virtual
CATEGORIES:Career Speaker Series
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Toronto:20220929T150000
DTEND;TZID=America/Toronto:20220929T160000
DTSTAMP:20260403T142647
CREATED:20220817T163705Z
LAST-MODIFIED:20220921T201635Z
UID:18120-1664463600-1664467200@mbd.ccrm.ca
SUMMARY:Conversations in Convergence: Kristin Hope\, PhD\, and Roshane Frances\, PhD
DESCRIPTION:Note: We are excited to transition Conversations in Convergence from a virtual to an in-person event\, providing more opportunity for networking and potential collaboration.  \nJoin us for our Conversations in Convergence series\, which features interactive discussions between Medicine by Design researchers who study similar questions using different approaches. \nThe theme of this conversation will be\, Targeted approaches to improving cell function for therapy. \nRegister Now \n \nSpeakers \nKristin Hope\, PhDSenior Scientist\, Princess Margaret Cancer Centre\, University Health Network\, and Associate Professor\, Department of Medical Biophysics\, University of Toronto  \nHarnessing post-transcriptional circuitries to maximize the therapeutic potential of hematopoietic stem cells \nKristin Hope obtained her PhD from the University of Toronto studying leukemic stem cells in the department of Molecular and Medical Genetics and followed this with a Post-doctoral Fellowship in stem cell functional genetics at the Université de Montreal. Dr. Hope began her independent research program as an Assistant Professor at McMaster University in 2010 and was recruited in 2020 by the Princess Margaret Cancer Centre\, University Health Network where she is a Senior Scientist and holds an Associate Professorship in the Department of Medical Biophysics at the University of Toronto. Dr. Hope also holds an Ontario Institute for Cancer Research Investigator Award and is a Medicine by Design Investigator. \n \n  \nRoshane Frances\, PhD Postdoctoral Research Fellow\, Keith Pardee lab\, Department of Pharmaceutical Sciences\, University of Toronto  \nTCR-CAR T cells: Engineering immune cells to treat cancer \nRoshane Frances is a recent SickKids PhD graduate currently working as a post-doctoral fellow in Dr. Pardee’s Lab at the University of Toronto. During her PhD\, she explored how the embryonic stomach develops in mice and used these insights to study gastric cancer initiation. Wanting to explore more translation specific opportunities\, her post-doctoral studies involved engineering drug-secreting bacteria for the treatment of inflammatory bowel diseases and CAR T-cells to target colon cancer cells! \n \nAbout Conversations in Convergence\n\nThe goal is to foster cross-disciplinary discussions in support of convergence\, which is the integration of approaches from engineering\, science\, medicine and other fields to expand knowledge and spark innovation. The researchers will discuss how their unique perspectives\, knowledge and ideas inform their work\, and how their diverse approaches intersect and complement one another to advance regenerative medicine. \n 
URL:https://mbd.ccrm.ca/event/conversations-in-convergence-kristin-hope-phd-and-roshane-frances-phd/
LOCATION:Donnelly Centre for Cellular and Biomolecular Research\, Red Room\, 160 College Street\, Toronto\, Ontario\, M5S 3E1\, Canada
CATEGORIES:Other Events
ORGANIZER;CN="Medicine by Design":MAILTO:info.mbd@utoronto.ca
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Toronto:20220927T120000
DTEND;TZID=America/Toronto:20220927T130000
DTSTAMP:20260403T142647
CREATED:20220322T175137Z
LAST-MODIFIED:20220322T175137Z
UID:16812-1664280000-1664283600@mbd.ccrm.ca
SUMMARY:Adipose Biology Seminar Series
DESCRIPTION:Please visit the discussion groups page for more information.
URL:https://mbd.ccrm.ca/event/adipose-biology-seminar-series-15/
LOCATION:Online
CATEGORIES:Discussion Groups
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Toronto:20220926T140000
DTEND;TZID=America/Toronto:20220926T150000
DTSTAMP:20260403T142647
CREATED:20220322T171902Z
LAST-MODIFIED:20220322T171902Z
UID:16805-1664200800-1664204400@mbd.ccrm.ca
SUMMARY:Myogenesis Discussion Group
DESCRIPTION:Please visit the discussion groups page for more information.
URL:https://mbd.ccrm.ca/event/myogenesis-discussion-group-15/
LOCATION:Online
CATEGORIES:Discussion Groups
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Toronto:20220920T120000
DTEND;TZID=America/Toronto:20220920T130000
DTSTAMP:20260403T142647
CREATED:20220627T132505Z
LAST-MODIFIED:20220815T210942Z
UID:17495-1663675200-1663678800@mbd.ccrm.ca
SUMMARY:Global Speaker Series: Gordon Fishell\, PhD – Harvard University
DESCRIPTION:The Medicine by Design Global Speaker Series invites established and emerging international leaders in regenerative medicine to engage with our extraordinary community of researchers and clinicians. Medicine by Design\, in partnership with the McEwen Stem Cell Institute\, is pleased to welcome Gordon Fishell\, PhD\, Professor of Neurobiology\, Harvard Medical School and the Stanley Center at the Broad. The title of this talk will be\, “The intimate dependence and remarkable precision of cortical interneurons.” In Person – Register Here \nVirtual – Register Here\nHybrid event\, with in-person and virtual options\n\nIn-person will be held at the Terrence Donnelly Centre for Cellular & Biomolecular Research\, Red Room.\nVirtual event links will be sent after registration.\n\nMore About gordon fishell:\nProfessor Fishell teaches in the department of Neurobiology at Harvard Medical center and is an institute member of the Broad institute. He was previously the associate director of the New York University (NYU) Neuroscience Institute\, Julius Raines Professor of Neuroscience and Physiology at NYU\, and director of the graduate program in neuroscience and physiology at the NYU School of Medicine. Professor Fishell completed his Ph.D. in neurobiology from the University of Toronto and conducted postdoctoral research at Columbia University and the Rockefeller University. His laboratory is interested in how the architecture of brain circuits are assembled\, with a special focus on the diverse populations of inhibitory interneurons that are found in both pallial and subpallial telencephalon. Professor Fishell’s laboratory has spent the past 20 years working to understand the inhibitory cells that regulate excitatory signaling in the brain. \n Learn more about Gordon Fishell
URL:https://mbd.ccrm.ca/event/global-speaker-series-gordon-fishell-phd-harvard-university/
LOCATION:Donnelly Centre for Cellular and Biomolecular Research\, Red Room\, 160 College Street\, Toronto\, Ontario\, M5S 3E1\, Canada
CATEGORIES:Global Speaker Series
ORGANIZER;CN="Medicine by Design":MAILTO:info.mbd@utoronto.ca
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Toronto:20220915T113000
DTEND;TZID=America/Toronto:20220915T123000
DTSTAMP:20260403T142647
CREATED:20220329T182708Z
LAST-MODIFIED:20220329T182708Z
UID:16863-1663241400-1663245000@mbd.ccrm.ca
SUMMARY:Modelling Cell Development & Regeneration Discussion Group
DESCRIPTION:Please visit the discussion groups page for more information.
URL:https://mbd.ccrm.ca/event/modelling-cell-development-regeneration-discussion-group-15/
LOCATION:Online
CATEGORIES:Discussion Groups
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Toronto:20220914T120000
DTEND;TZID=America/Toronto:20220914T130000
DTSTAMP:20260403T142647
CREATED:20220714T163601Z
LAST-MODIFIED:20220826T135457Z
UID:17717-1663156800-1663160400@mbd.ccrm.ca
SUMMARY:Careers Beyond Academia - Laura Smith\, PhD Principal Scientist\, AmacaThera and Stephanie Fisher\, PhD Senior Scientist\, BlueRock Therapeutics
DESCRIPTION:About the series \nTo what extent can we plan and design our careers? How much depends on our environment\, the choices we make\, the opportunities that present themselves\, the networks we build\, and the achievements and failures we experience along the way? Medicine by Design and Stem Cell Network have partnered to host Careers Beyond Academia\, a virtual career seminar series that will profile a wide variety of different careers available to trainees who hold a degree in the life sciences. The goal of the series is to help trainees understand the different careers available outside of academia\, the skills required for certain positions\, and some of the daily functions of those positions. \nVirtual Event – Register Here\nSpeakers:\n\nLaura Smith\, PhDPrincipal Scientist\, AmacaThera\nStephanie Fisher\, PhDSenior Scientist\, BlueRock Therapeutics\n\nEach session will feature two speaker presentations that will be recorded and available on both Medicine by Design and Stem Cell Network’s website and YouTube channel. Trainees will be able to participate in a joint Q&A and panel discussion during the session. \n 
URL:https://mbd.ccrm.ca/event/beyond-academia-speaker-tbc-3/
LOCATION:Virtual
CATEGORIES:Career Speaker Series
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Toronto:20220829T120000
DTEND;TZID=America/Toronto:20220829T130000
DTSTAMP:20260403T142647
CREATED:20220322T174534Z
LAST-MODIFIED:20220322T174534Z
UID:16810-1661774400-1661778000@mbd.ccrm.ca
SUMMARY:Adipose Biology Seminar Series
DESCRIPTION:Please visit the discussion groups page for more information.
URL:https://mbd.ccrm.ca/event/adipose-biology-seminar-series-14/
LOCATION:Online
CATEGORIES:Discussion Groups
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Toronto:20220818T113000
DTEND;TZID=America/Toronto:20220818T123000
DTSTAMP:20260403T142647
CREATED:20220329T182630Z
LAST-MODIFIED:20220329T182630Z
UID:16864-1660822200-1660825800@mbd.ccrm.ca
SUMMARY:Modelling Cell Development & Regeneration Discussion Group
DESCRIPTION:Please visit the discussion groups page for more information.
URL:https://mbd.ccrm.ca/event/modelling-cell-development-regeneration-discussion-group-14/
LOCATION:Online
CATEGORIES:Discussion Groups
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Toronto:20220804T113000
DTEND;TZID=America/Toronto:20220804T123000
DTSTAMP:20260403T142647
CREATED:20220329T180717Z
LAST-MODIFIED:20220329T180717Z
UID:16865-1659612600-1659616200@mbd.ccrm.ca
SUMMARY:Modelling Cell Development & Regeneration Discussion Group
DESCRIPTION:Please visit the discussion groups page for more information.
URL:https://mbd.ccrm.ca/event/modelling-cell-development-regeneration-discussion-group-13/
LOCATION:Online
CATEGORIES:Discussion Groups
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Toronto:20220725T140000
DTEND;TZID=America/Toronto:20220725T150000
DTSTAMP:20260403T142647
CREATED:20220322T171443Z
LAST-MODIFIED:20220322T171443Z
UID:16797-1658757600-1658761200@mbd.ccrm.ca
SUMMARY:Myogenesis Discussion Group
DESCRIPTION:Please visit the discussion groups page for more information.
URL:https://mbd.ccrm.ca/event/myogenesis-discussion-group-12/
LOCATION:Online
CATEGORIES:Discussion Groups
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Toronto:20220725T120000
DTEND;TZID=America/Toronto:20220725T130000
DTSTAMP:20260403T142647
CREATED:20220322T174500Z
LAST-MODIFIED:20220322T174500Z
UID:16182-1658750400-1658754000@mbd.ccrm.ca
SUMMARY:Adipose Biology Seminar Series
DESCRIPTION:Please visit the discussion groups page for more information.
URL:https://mbd.ccrm.ca/event/adipose-biology-seminar-series-13/
LOCATION:Online
CATEGORIES:Discussion Groups
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Toronto:20220721T113000
DTEND;TZID=America/Toronto:20220721T123000
DTSTAMP:20260403T142647
CREATED:20220329T180652Z
LAST-MODIFIED:20220329T180652Z
UID:16866-1658403000-1658406600@mbd.ccrm.ca
SUMMARY:Modelling Cell Development & Regeneration Discussion Group
DESCRIPTION:Please visit the discussion groups page for more information.
URL:https://mbd.ccrm.ca/event/modelling-cell-development-regeneration-discussion-group-8/
LOCATION:Online
CATEGORIES:Discussion Groups
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Toronto:20220706T143000
DTEND;TZID=America/Toronto:20220706T153000
DTSTAMP:20260403T142647
CREATED:20220615T184809Z
LAST-MODIFIED:20220622T143150Z
UID:17410-1657117800-1657121400@mbd.ccrm.ca
SUMMARY:Conversations in Convergence: Jesse Gillis\, PhD\, and Alaura Androschuk
DESCRIPTION:Note: We are excited to transition Conversations in Convergence from a virtual to an in-person event\, providing more opportunity for networking and potential collaboration.  \nJoin us for our Conversations in Convergence series\, which features interactive discussions between Medicine by Design researchers who study similar questions using different approaches. \nThe theme of this conversation will be\, “Immune modulation by extrinsic and environmental factors.” \nRegister now \n \nSpeakers \nAlaura Androschuk \, PhD candidate in Michael Sefton’s lab\, Institute of Biomedical Engineering and the Department of Chemical Engineering & Applied Chemistry.  \nIdentifying signalling pathways underlying biomaterial-driven terminal axon growth using single nucleus RNA-sequencing \nAlaura Androschuk is a PhD candidate focusing on the use of biomaterials for endogenous repair of tissues\, specifically subcutaneous nerve regeneration. Under the supervision of  Michael Sefton\, she has focused in part on identifying the signalling pathways and cells underlying the biomaterial-driven repair of complex tissues using proteomics and single nucleus transcriptomics. \n \nJesse Gillis\, Associate Professor and Bassingthwaighte Chair in Integrative Physiology\, Department of Physiology\, University of Toronto.  \nBuffered and unbuffered cell lineage variability \nJesse Gillis completed his undergraduate in Biophysics at the University of Toronto\, where he also received his PhD in Neuroscience in 2007. His post-doctoral training was done at the Centre for High-throughput Biology at UBC. There\, he focused on meta-analysis of expression data\, and particularly co-expression analysis\, which infers functionality between genes based on shared expression profiles\, a form of network analysis. Jesse joined the faculty of CSHL in 2012 with a central focus on improving network analysis. In 2017\, he was promoted to Associate Professor at CSHL with his work focusing on single cell analysis\, particularly in collaboration with researchers in the BRAIN Initiative Cell Census Network. In 2022\, Jesse returned to U of T as the inaugural Bassingthwaighte Chair in Integrative Physiology and a Medicine by Design investigator. \n \nAbout Conversations in Convergence\n\nThe goal is to foster cross-disciplinary discussions in support of convergence\, which is the integration of approaches from engineering\, science\, medicine and other fields to expand knowledge and spark innovation. The researchers will discuss how their unique perspectives\, knowledge and ideas inform their work\, and how their diverse approaches intersect and complement one another to advance regenerative medicine. \n 
URL:https://mbd.ccrm.ca/event/conversations-in-convergence-jessis-gillis-phd-and-alaura-androschuk/
LOCATION:Donnelly Centre for Cellular and Biomolecular Research\, Red Room\, 160 College Street\, Toronto\, Ontario\, M5S 3E1\, Canada
CATEGORIES:Other Events
ORGANIZER;CN="Medicine by Design":MAILTO:info.mbd@utoronto.ca
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Toronto:20220628T120000
DTEND;TZID=America/Toronto:20220628T130000
DTSTAMP:20260403T142647
CREATED:20211021T185953Z
LAST-MODIFIED:20211021T185953Z
UID:15647-1656417600-1656421200@mbd.ccrm.ca
SUMMARY:Adipose Biology Seminar Series
DESCRIPTION:Please visit the discussion groups page for more information.
URL:https://mbd.ccrm.ca/event/adipose-biology-seminar-series-11/
LOCATION:Online
CATEGORIES:Discussion Groups
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Toronto:20220627T140000
DTEND;TZID=America/Toronto:20220627T150000
DTSTAMP:20260403T142647
CREATED:20220322T171327Z
LAST-MODIFIED:20230119T133116Z
UID:16798-1656338400-1656342000@mbd.ccrm.ca
SUMMARY:Myogenesis Discussion Group
DESCRIPTION:Please visit the discussion groups page for more information.
URL:https://mbd.ccrm.ca/event/myogenesis-discussion-group-11/
LOCATION:Online
CATEGORIES:Discussion Groups
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Toronto:20220623T113000
DTEND;TZID=America/Toronto:20220623T123000
DTSTAMP:20260403T142647
CREATED:20220329T180510Z
LAST-MODIFIED:20220329T180510Z
UID:16858-1655983800-1655987400@mbd.ccrm.ca
SUMMARY:Modelling Cell Development & Regeneration Discussion Group
DESCRIPTION:Please visit the discussion groups page for more information.
URL:https://mbd.ccrm.ca/event/modelling-cell-development-regeneration-discussion-group-12/
LOCATION:Online
CATEGORIES:Discussion Groups
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Toronto:20220621T120000
DTEND;TZID=America/Toronto:20220621T130000
DTSTAMP:20260403T142647
CREATED:20220517T170108Z
LAST-MODIFIED:20220615T211439Z
UID:17239-1655812800-1655816400@mbd.ccrm.ca
SUMMARY:Global Speaker Series: Gilbert Bernier\, PhD - Université de Montréal
DESCRIPTION:The Medicine by Design Global Speaker Series invites established and emerging international leaders in regenerative medicine to engage with our extraordinary community of researchers and clinicians. \nMedicine by Design\, in partnership with the McEwen Stem Cell Institute\, is pleased to welcome Gilbert Bernier\, PhD\, Associate Professor in the Department of Neuroscience at Université de Montréal. \nThe title of this talk will be\, “Cone photoreceptor sheet transplantation for the treatment of macular degenerations” \nRegister now \nHybrid event\, with in-person and virtual options\n\nIn-person will be held at the Terrence Donnelly Centre for Cellular & Biomolecular Research\, Red Room.\nVirtual event links will be sent after registration.\n\n \nMore About Gilbert bernier:\nProfessor Gilbert Bernier performed is graduated studies in Molecular Biology at Montreal University where he characterized the gene mutated in the mouse neurological disorder dystonia musculorum. In 1997\, he moved to the Max-Planck Institute of Biophysical Chemistry in Germany to study developmental biology of the retina. Since 2001\, he is heading the laboratory of stem cell and developmental biology at Maisonneuve-Rosemont Hospital to exploit the potential of human pluripotent stem cells for the study and treatment of neurodegenerative diseases such as retinal degenerative diseases and Alzheimer’s disease. Professor Bernier has also contributed to the characterization of Polycomb group proteins function in brain cancer\, DNA repair\, and premature ageing. He is Professor at the Neuroscience Department of Montreal University since 2012. He is co-founder and CEO of StemAxonTM\, a Canadian corporation involved in the development of new treatments for neurodegenerative diseases. \n Learn more about Gilbert Bernier
URL:https://mbd.ccrm.ca/event/global-speaker-series-gilbert-bernier-phd-universite-de-montreal/
LOCATION:Donnelly Centre for Cellular and Biomolecular Research\, Red Room\, 160 College Street\, Toronto\, Ontario\, M5S 3E1\, Canada
CATEGORIES:Global Speaker Series
ORGANIZER;CN="Medicine by Design":MAILTO:info.mbd@utoronto.ca
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Toronto:20220609T130000
DTEND;TZID=America/Toronto:20220609T150000
DTSTAMP:20260403T142647
CREATED:20220509T192249Z
LAST-MODIFIED:20220512T104931Z
UID:17164-1654779600-1654786800@mbd.ccrm.ca
SUMMARY:Spotlight on Clinical Translation: Making the leap from the lab bench to Phase I Clinical Trials
DESCRIPTION:  \nJoin us for Spotlight on Clinical Translation: Making the leap from the lab bench to Phase I Clinical Trials\, hosted by The Stem Cell Network and Medicine by Design. \nThis workshop will provide investigators and trainees with a basic understanding of the clinical pipeline\, from essential pre-clinical studies to Phase I first in human trials. The invited speakers will review processes involved in clinical trial submission\, regulatory approval and product manufacturing. An interactive Q&A session will ensure participants can ask questions relevant to their research along with leveraging this opportunity to connect with clinical trial experts. \nClinical studies are a key element on the pathway of translational cell and gene therapies. It is\, therefore\, essential that principal investigators\, researchers\, trainees\, clinical research fellows and ecosystem partners working in Canada undertaking translational research have a thorough understanding of the clinical trial pipeline; focused specifically on the early phase clinical trial design processes. \nRegister now! \n \nRegistration deadline: \nAttendance at this event is limited; all those interested in participating must register by June 8\, 2022\, at 11:59 PM local time. \nView Agenda \n1:00-1:05 pm ET – Opening Remarks\nModerators: Harold Atkins and Darshan Brahmbhatt \n1:05-1:40 pm ET – Presentation by Natasha Kekre\, MD\, Hematologist\, The Ottawa Hospital Transplant and Cellular Therapy Program\, and Scientist\, Ottawa Hospital Research Institute \nPresentation title: Building the pre-CTA and CTA package for Phase I trials: Case study using CLIC CAR-T trial for relapsed/refractory CD19 positive hematologic malignancies \n1:45-2:10 pm ET – Presentation by Patrick Bedford\, MSc\, Managing Director\, weCANreg Consulting Group Inc. \nPresentation title: Leveraging a regulatory rerspective on your path to trials \n2:15-2:40 pm ET – Presentation by Linh Nguyen\, PhD\, Staff Scientist/Head\, Cell Manufacturing Team\, Tumor Immunotherapy Program\, Princess Margaret Cancer Centre \nPresentation title: Developing a cell manufacturing process for an early phase clinical trial \n2:40-2:45 pm ET – Break \n2:45-3:00 pm ET – General Discussion/Q&A session \n3:00 pm ET – Closing Remarks \n \n\nSpeaker and Chair Details \nSPEAKERS\nPatrick BedfordNatasha KekreLinh NguyenPatrick Bedford \nPatrick Bedford\, MSc – Managing Director\, weCANreg Consulting Group Inc. \nPatrick Bedford is an experienced and certified regulatory professional who is focused on facilitating global regenerative medicine development. He founded & operates weCANreg Consulting Group Inc.\, which provides regulatory strategy\, interaction\, and submission services. Furthermore\, Patrick is VP of Regulatory & Development at Artisan Bio\, which is a CRISPR-enabled multiplex cell engineering company making precision immunotherapies. In his spare time\, he remains an active educator and contributor to regulatory policy development. \nPrior to incorporating his own company and leading regulatory strategy at Artisan Bio\, Patrick developed regulatory consulting services for a regenerative medicine Network Centre of Excellence; planned 2 Canadian CAR-T New Drug Submissions; and led teams at Health Canada responsible for developing guidance for biosimilars\, transplant material\, and cell & gene therapies. While leading these policy initiatives at Health Canada\, Patrick also supported their Therapeutic Products Classification Committee; chaired the Cells\, Tissues\, and Organs Classification Committee; and championed international harmonization initiatives. \nPatrick completed an Honours Bachelor of Health Sciences degree at the University of Western Ontario\, a Master’s degree in Bioethics and Health Law at the University of Otago\, a Regulatory Affairs Certificate from the Regulatory Affairs Professional Society\, and is pursuing his MBA at the Jack Welch Management Institute. \nNatasha Kekre \nNatasha Kekre\, MD – Hematologist\, The Ottawa Hospital Transplant and Cellular Therapy Program\, and Scientist\, Ottawa Hospital Research Institute\n \nDr. Natasha Kekre has been appointed to the Department of Medicine in the Division of Hematology\, within the Transplant and Cellular Therapy Program at The Ottawa Hospital\, effective October 2015. She is also an associate scientist within the Ottawa Hospital Research Institute and an associate professor of medicine at the University of Ottawa. She completed her Bachelor’s in Science at the University of Windsor then obtained her medical degree from the University of Ottawa. She then trained at the University of Ottawa in Internal Medicine and Hematology. She went on to do a fellowship in stem cell transplantation at Dana Farber Cancer Institute in Boston\, MA with a Masters in Public Health from Harvard University. \nHer research is focused on developing early phase clinical trials and moving home grown therapeutic strategies into patients. She collaborates with a number of local investigators and scientists in Ottawa\, studying hematologic malignancies and blood and marrow transplant recipients more specifically. She collaborates with scientists and physicians across Canada to build a Canadian CAR-T cell platform (chimeric antigen receptor T cells are immune cells engineered to kill cancer cells)\, bringing this exciting new therapy to Canadian patients. Her other clinical research interests include improving transplant related outcomes and projects with an epidemiologic focus\, including but not limited to decision modeling and meta-analyses. \nShe also participates with a number of cooperative groups in North America including the Center for International Blood and Marrow Transplant Research\, the Canadian Blood and Marrow Transplant Group\, the American Society of Hematology and the American Society for Transplant and Cellular Therapy. \nLinh Nguyen \nLinh Nguyen\, PhD – Staff Scientist/Head\, Cell Manufacturing Team\, Tumor Immunotherapy Program\, Princess Margaret Cancer Centre \nDr. Linh Nguyen has led the Cell Manufacturing Team of the Tumor Immunotherapy Program at the Princess Margaret Cancer Centre since 2005. Dr. Nguyen obtained her PhD in Immunology at the University of Toronto and pursued postdoctoral studies at Harvard Medical School. Her interests include tumor immunology and immunotherapy. Her team has manufactured cell and gene therapy products for clinical trials such as tumor-infiltrating lymphocytes (TILs)\, dendritic cells and T cell receptor gene-engineered T cells. The team’s activities also include quality assurance\, quality control\, and preparation of regulatory submissions. \n \nCHAIR\nHarold AtkinsDarshan H. BrahmbhattHarold Atkins \nHarold Atkins\, MD – Attending Physician\, The Ottawa Hospital Transplant and Cell Therapy Program\, and Scientist\, Ottawa Hospital Research Institute \nDr. Harry Atkins is a physician of The Ottawa Hospital Transplant and Cell Therapy Program\, an Associate Professor of Medicine at the University of Ottawa\, and a scientist in the Ottawa Hospital Research Institute’s Center for Innovative Cancer Research. \nHe received his Bachelor of Medical Science degree and Medical Degree from the University of Ottawa followed by a rotating internship year at the Victoria General Hospital in Victoria BC. Specialty training in Internal Medicine was done at the University of Ottawa. Clinical and research fellowships in Hematology\, Stem Cell Transplantation and Experimental Hematology followed at the University of Washington and at the Ontario Cancer Institute. \nHe specializes in hematopoietic stem cell transplantation and has spearheaded the use of stem cell transplantation for immune repair to treat patients with severe autoimmune diseases including multiple sclerosis\, scleroderma\, myasthenia gravis and others. The outcome of a trial using autologous hematopoietic stem cell transplantation to treat multiple sclerosis was published in the Lancet in 2016. He ran a clinical trial exploring the role of hematopoietic stem cell transplantation in preventing organ transplant rejection. He is a member of a BiocanRx funded\, pan-Canadian consortium to develop and improve the accessibility of new chimeric antigen receptor T lymphocytes for the treatment of hematological cancers. He was awarded the OHRI’s Dr. Michel Chretien Researcher of the Year in 2016\, the Till and McCulloch Award from the Stem Cell Network in 2017 and was the co-recipient of the Canadian Blood Services Lifetime Achievement Award in 2019. \nDarshan H. Brahmbhatt \nDarshan H. Brahmbhatt – MA MB BChir MPhil MRCS MRCP CCDS\, Ted Rogers Centre for Heart Function and Ajmera Transplant Centre\, University of Toronto \nDr. Darshan H. Brahmbhatt is a cardiologist who joined the UoT & TGH HF/Transplant team as a clinical fellow from London\, UK in October 2019\, having completed his doctoral research at the Royal Brompton Hospital and heart failure/device implantation training before that at Royal Papworth Hospital\, Cambridge.  His research focusses on implementation of remote monitoring and digital health solutions to assist clinicians make better decisions in managing patients with heart failure. He is currently supported by TRANSFORM-HF in his post-doctoral studies.
URL:https://mbd.ccrm.ca/event/spotlight-on-clinical-translation-making-the-leap-from-the-lab-bench-to-phase-i-clinical-trials/
LOCATION:Virtual
CATEGORIES:Co-hosted Events
ORGANIZER;CN="Medicine by Design":MAILTO:info.mbd@utoronto.ca
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Toronto:20220609T113000
DTEND;TZID=America/Toronto:20220609T123000
DTSTAMP:20260403T142647
CREATED:20211021T192247Z
LAST-MODIFIED:20211021T192308Z
UID:15677-1654774200-1654777800@mbd.ccrm.ca
SUMMARY:Modelling Cell Development & Regeneration Discussion Group
DESCRIPTION:Please visit the discussion groups page for more information.
URL:https://mbd.ccrm.ca/event/modelling-cell-development-regeneration-discussion-group-11/
LOCATION:Online
CATEGORIES:Discussion Groups
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Toronto:20220531T120000
DTEND;TZID=America/Toronto:20220531T130000
DTSTAMP:20260403T142647
CREATED:20211021T185847Z
LAST-MODIFIED:20211021T185920Z
UID:15645-1653998400-1654002000@mbd.ccrm.ca
SUMMARY:Adipose Biology Seminar Series
DESCRIPTION:Please visit the discussion groups page for more information.
URL:https://mbd.ccrm.ca/event/adipose-biology-seminar-series-10/
LOCATION:Online
CATEGORIES:Discussion Groups
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Toronto:20220530T150000
DTEND;TZID=America/Toronto:20220530T170000
DTSTAMP:20260403T142647
CREATED:20220428T214037Z
LAST-MODIFIED:20220517T140217Z
UID:17094-1653922800-1653930000@mbd.ccrm.ca
SUMMARY:Pitch Competition: Building a Biotech Venture program
DESCRIPTION:  \nRegister to join the audience at the 2022 Pitch Competition!\nJoin us in-person on May 30 for the Building a Biotech Venture Pitch Competition to learn how the next generation of regenerative and precision medicine researchers are preparing to translate their discoveries toward impact. \nWatch as six trainee-led teams from the University of Toronto and its affiliated hospitals pitch their ventures to an expert panel of judges. The winning team will receive $25\,000\, and the second-place team will receive $10\,000 in research funding to advance their product concept.  \nRegister now \nThe competition is the culmination of Medicine by Design’s Building a Biotech Venture program\, offered in partnership with Precision Medicine Initiative (PRiME)\, the Health Innovation Hub (H2i) and Talk Boutique. Over the last six months\, teams have worked with mentors to advance early-stage company concepts based on their research. \nCome cheer on these up-and-coming entrepreneurs as they showcase their innovative technologies! \nNOTE: This event will be held in-person in accordance with the University of Toronto’s COVID-19 policies. Masks are required in indoor spaces where physical distancing cannot be maintained. \n \nMeet the judges\nAlberto GalassoElla Korets-Smith Angela MacDonaldRobin QuirkAlberto Galasso \n \n  \nAlberto Galasso\, PhD\nProfessor of Strategic Management\nRotman School of Management\, University of Toronto\nRead more \nElla Korets-Smith  \n\nElla Korets-Smith\, MBA\, MSc\nChief Business Officer\, Virica Biotech\nRead more \nAngela MacDonald \nAngela McDonald\, PhD\nEntrepreneur-in-Residence\, Versant Ventures\nRead more \nRobin Quirk \nRobin Quirk\, PhD\, MBA\nVice President\, Technology Sourcing & Venture Development\, CCRM\nRead more \n \n \n\nMeet the teams\nAzane Therapeutics\nDelivering the promise of RNA therapy.\nLab: Institute of Biomedical Engineering and Department of Immunology\, University of Toronto \nThis company’s product\, a delivery vehicle for mRNA-based therapies\, has the potential to make it possible for rare diseases to be treated with mRNA. The platform could also apply to regenerative medicine treatments such as stem cell reprogramming and inflammatory disorders. \n \nDTPX Therapeutics\nDeveloping immunotherapy against hibernating drug tolerant cancer cells for colorectal cancer patients.\nLab: Princess Margaret Cancer Centre\, University Health Network; and Donnelly Centre for Cellular and Biomolecular Research\, University of Toronto. \nWhen individuals are treated for colorectal cancer with standard chemotherapy\, a cell population that’s resistant to treatment can “hibernate” and re-emerge after treatment\, causing the tumour to relapse. DTXP Therapeutics aims to create a platform that can selectively target these hibernating cells to reduce the chance of relapse\, potentially benefiting many types of cancer.\n \nGlusyn Diagnostics\nAutomated PCR-free diagnostic systems for rapid\, low-cost\, distributed usage.\nLab: Leslie Dan Faculty of Pharmacy\, University of Toronto. \nWith mastitis in dairy cows as a use-case\, this teams aims to develop automated PCR-free diagnostic systems that are shelf-stable and have low manufacturing costs.\n \nA2O\nReprogramming for recovery.\nLab: Division of Anatomy\, University of Toronto. \nA2O has developed a type of gene therapy to convert toxic brain cells back into healthy cells to treat chronic neurodegenerative disease such as multiple sclerosis and Alzheimer’s disease\, as well as acute neurological injuries such as spinal cord injury. This therapy allows for a targeted approach that can be tailored to disease type\, stage or severity.\n \nOne Drug\nEnabling next generation drugs.\nLabs: Leslie Dan Faculty of Pharmacy\, University of Toronto; Institute of Biomedical Engineering\, University of Toronto; and Department of Chemistry\, University of Toronto.\n \nDeveloping clinical point-of-care diagnostic devices that will enable clinicians and drug developers identify patients at risk of adverse drug reactions and/or suboptimal drug response based on their genetic makeup.\n \nScivance\nDeveloping therapeutics for rare disease.\nLab: Department of Chemical & Physical Sciences\, University of Toronto Mississauga \nOnly five percent of rare diseases have treatments\, and a substantial portion of these rare diseases are caused by genes called fusion oncogenes. This team is developing a proprietary algorithm and multi-disciplinary pipeline which lies at the intersection of medicinal chemistry\, structural biophysics and molecular biology\, which can help develop treatments for these disease drivers.
URL:https://mbd.ccrm.ca/event/pitch-competition-biotech-venture-2022/
LOCATION:Leslie Dan Pharmacy Building Room PB B250\, 144 College St\, Toronto\, M5S 3M2\, Canada
CATEGORIES:Co-hosted Events
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Toronto:20220530T140000
DTEND;TZID=America/Toronto:20220530T150000
DTSTAMP:20260403T142647
CREATED:20220322T171250Z
LAST-MODIFIED:20220322T171250Z
UID:16799-1653919200-1653922800@mbd.ccrm.ca
SUMMARY:Myogenesis Discussion Group
DESCRIPTION:Please visit the discussion groups page for more information.
URL:https://mbd.ccrm.ca/event/myogenesis-discussion-group-10/
LOCATION:Online
CATEGORIES:Discussion Groups
END:VEVENT
END:VCALENDAR